ArticleHealth economics review2018
Potential gains in life expectancy by eliminating deaths from cardiovascular diseases and diabetes mellitus in the working life ages among Slovak population.
Article in Health economics review, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 10 citations in OpenAlex.
- Article
- Association between the Standardized Mortality Ratio and Healthy Life Expectancy in Japan.JMA journal · 2023Article
- Mortality transition over a quarter century in rural South Africa: findings from population surveillance in Agincourt 1993-2018.Global health action · 2021Article
- Relationships between Renewable Energy and the Prevalence of Morbidity in the Countries of the European Union: A Panel Regression Approach.International journal of environmental research and public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
backgroundIn recent years, high mortality from cardiovascular diseases (chronic ischemic heart disease, acute coronary syndrome, cerebrovascular diseases, atherosclerosis, hypertensive diseases) and diabetes mellitus have burdened economic and health system of the Slovak Republic considerably. By eliminating these deaths, the life expectancy could be prolonged. Since the mortality of population during working period has higher importance in terms of economic consequences of diseases, this article aims to assess the potential gains in life expectancy (PGLEs) of the Slovak population comparing the entire life span and working life-time.
methodsData are obtained from the National Health Information Center mortality reports by sex during 1996-2014, and the method of constructing abridged life tables is used to compute the corresponding PGLEs. The added years, which would be gained by eliminating causes of deaths, are decomposed by the two sets of working age groups population (25-44 and 45-64 years).
resultsThe highest impact on life expectancy was recorded in chronic ischemic heart disease for both sexes aged 45-64 years (0.078 for males, 0.019 added years for females) over 1996-2014. However, they showed a small declining trend (- 16%) for males and even an increasing trend (2%) for females. At present, the labour force potential of working group (25-44 years) is most threatened by deaths from cerebrovascular diseases, while population of working age (45-64 years) by deaths from chronic ischemic heart disease. Relative importance of acute coronary syndrome for males (45-64 years) increased, when comparing the entire with working time life.
conclusionsThe findings pose new and immediate challenges to policy makers and provoke discussion about prevention program strategies leading to increasing the life expectancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.